Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Somnomed Limited (AU:SOM)
:SOM
SOM Stock Chart & Stats
Day’s Range― - ―
52-Week RangeAU$0.19 - AU$0.70
Previous CloseN/A
Volume51.81K
Average Volume (3M)88.31K
Market Cap
AU$127.50M
Enterprise ValueAU$34.96M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.32
Next Earnings
Feb 28, 2025EPS Estimate
<0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.09
Shares Outstanding216,108,250
10 Day Avg. Volume50,592
30 Day Avg. Volume88,313
Standard Deviation0.20
R-Squared0.20
Alpha-0.01
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.90
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$0.80Price Target Upside36.02% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
---
Somnomed Limited News
PremiumCompany Announcements
SomnoMed to Announce H1FY25 Financial Results and Host Investor Webinar
PremiumCompany Announcements
SomnoMed Limited Reports Positive Cash Flow Amidst Investment Outflows
PremiumCompany Announcements
SomnoMed Limited Updates FY25 Guidance with Strong Revenue Growth
PremiumCompany Announcements
SomnoMed Strengthens Leadership with New Director Appointment
PremiumCompany Announcements
SomnoMed Appoints Andrew Price as New Director to Enhance Global OperationsPremiumCompany Announcements
Somnomed Limited: Director Acquires 300,000 Options
PremiumCompany Announcements
Somnomed Limited Director Increases Options Holdings---
Options Prices
Currently, No data available
---
Ownership Overview
SOM FAQ
What was Somnomed Limited’s price range in the past 12 months?
Somnomed Limited lowest share price was AU$0.19 and its highest was AU$0.69 in the past 12 months.
What is Somnomed Limited’s market cap?
Somnomed Limited’s market cap is AU$127.50M.
When is Somnomed Limited’s upcoming earnings report date?
Somnomed Limited’s upcoming earnings report date is Feb 28, 2025 which is in 6 days.
How were Somnomed Limited’s earnings last quarter?
Somnomed Limited released its earnings results on Aug 27, 2024. The company reported -AU$0.007 earnings per share for the quarter, missing the consensus estimate of -AU$0.003 by -AU$0.004.
Is Somnomed Limited overvalued?
According to Wall Street analysts Somnomed Limited’s price is currently Undervalued.
Does Somnomed Limited pay dividends?
Somnomed Limited does not currently pay dividends.
What is Somnomed Limited’s EPS estimate?
Somnomed Limited’s EPS estimate is <0.01.
How many shares outstanding does Somnomed Limited have?
Somnomed Limited has 216,108,250 shares outstanding.
What happened to Somnomed Limited’s price movement after its last earnings report?
Somnomed Limited reported an EPS of -AU$0.007 in its last earnings report, missing expectations of -AU$0.003. Following the earnings report the stock price went up 2.667%.
Which hedge fund is a major shareholder of Somnomed Limited?
Currently, no hedge funds are holding shares in AU:SOM
---
Somnomed Limited Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
AU$0.80 (36.02% Upside)
AU$0.80 (36.02% Upside)
Insider Transactions
Bought Shares
Worth $188.4K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
91.66%
12-Months-Change
Fundamentals
Return on Equity
-35.66%
Trailing 12-Months
Asset Growth
12.07%
Trailing 12-Months
Company Description
Somnomed Limited
SomnoMed Ltd produces and sells oral treatment of sleep related disorder devices. It manufactures and designs premium oral appliances for the treatment of sleep disordered breathing relieving conditions. Its products include SomnoDent oral appliance for obstructive sleep apnea; and SomnoBrux, a mouthguard, which protects patients from teeth grinding damage, as well as SomTabs for cleaning its devices.
---
SOM Stock 12 Month Forecast
Average Price Target
AU$0.80
▲(36.02% Upside)
Technical Analysis
Ansell
―
Cochlear Limited
―
Fisher & Paykel Healthcare Corporation Limited
―
Ramsay Health Care
―
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
―
Best Analysts Covering SOM
1 Year
1 Year Success Rate
2/9 ratings generated profit
1 Year Average Return
-19.34%
reiterated a buy rating 26 days ago
Copying Shane Storey's trades and holding each position for 1 Year would result in 22.22% of your transactions generating a profit, with an average return of -19.34% per trade.
---